Resistance of human fungal pathogens to antifungal drugs

Current Opinion in Microbiology

Volumn 5, Issue 4, 2002, Pages 379-385

  Sanglard, Dominique ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYLAMINE; AMOROLFINE; AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MORPHOLINE DERIVATIVE; POLYENE ANTIBIOTIC AGENT; POSACONAZOLE; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE; TERBINAFINE; VORICONAZOLE;

ALLELE; BIOFILM; FUNGICIDE RESISTANCE; GENE EXPRESSION; GENE ISOLATION; GENE MUTATION; NONHUMAN; REVIEW;

EID: 0036342893     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(02)00344-2     Document Type: Review

References (50)

1. Translation elongation factor 2 is part of the target for a new family of antifungals
2. Identification of Saccharomyces cerevisiae isoleucyl-tRNA synthetase as target of G1-specific inhibitor reveromycin A
3. Secular trends in the epidiemology of nosocomial fungal infections in the United States
4. Resistance of Candida species to antifungal agents: Molecular mechanisms and clinical consequences
5. Antifungal drug resistance of pathogenic fungi
6. Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation
7. Antifungal drug susceptibility testing and resistance in Aspergillus
8. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance
9. Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance
10. Multiple resistance mechanisms to azole antifungals in yeast clinical isolates
11. Molecular basis of resistance to azole antifungals
12. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans
13. Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining
14. Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents
15. Molecular biological characterization of an azole-resistant Candida glabrata isolate
16. Resistance mechanisms in clinical isolates of Candida albicans
17. Mechanism of fluconazole resistance in Candida krusei
18. Aspergillus furnigatus CYP51 sequence: Potential basis for fluconazole resistance
19. Identification of two different 14-alpha sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus
20. Amino acid substitutions in the cytochrome P-450 lanosterol 14α-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents
21. Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors
22. Multiple functions of Pmt1p-mediated protein O-mannosylation in the fungal pathogen Candida albicans
23. Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: Drug susceptibility studies in erg6 mutants
24. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
25. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterization of CDR2, a new multidrug ABC transporter gene
26. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis
27. Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750
28. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents
29. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata
30. Induced expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in response to itraconazole
31. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters
32. Targeted gene disruption in Candida albicans wild-type strains: The role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates
33. MDR1-mediated drug resistance in Candida dubliniensis
34. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors
35. Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR
36. Homozygosity at the Candida albicans MTL locus associated with azole resistance
37. A common drug responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance
38. Identification of polymorphic mutant alleles of CaMDR1, a major facilitator of Candida albicans which confers multidrug resistance, and its in vitro transcriptional activation
39. Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor
40. AP1-mediated multidrug resistance in Saccharomyces cerevisiae requires FLR1 encoding a transporter of the major facilitator superfamily
41. Regulation of the yeast Yap1p nuclear export signal is mediated by redox signal-induced reversible disulfide bond formation
42. The bZip transcription factor Cap1p is involved in multidrug resistance and oxidative stress response in Candida albicans
43. Multiple Pdr1p/Pdr3p binding sites are essential for normal expression of the ATP binding cassette transporter protein-encoding gene PDR5
44. Functional isolation of the Candida albicans FCR3 gene encoding a bZip transcription factor homologous to Saccharomyces cerevisiae Yap3p
45. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients
46. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia
47. Biofilm formation by Candida dubliniensis
48. Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance
49. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms
50. Population genomics of drug resistance in Candida albicans